Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

14.83 -0.04 (-0.27%)
Streaming Delayed Price Updated: 12:27 PM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
News headline image
Compass Pathways Goes On Bad Trip, Despite 'Positive' Results From Psilocybin Trial ↗
Shares plunged, despite a psilocybin-based drug reducing depression in a trial. 
Via Investor's Business Daily
This Could Be The Next Multi-Billion AI Breakthrough
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – November 5, 2021 – There’s a massive announcement set to take place later this year, and it could change the $12 trillion... 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Compass Pathways 2.0: A New Rally In Psychedelic Stocks? ↗
Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat? 
Via Talk Markets
Topics Initial Public Offering
Psychedelics Offer Hope for Mental Disorders, Addiction
Via Investor Brand Network
News headline image
How This Company Is Using Psychedelic Medicines and Therapies to Treat Addiction and Mental Illness ↗
Courtesy of: MindMed The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored c... 
Via Benzinga
News headline image
Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders? ↗
Much like cannabis, psychedelics are catch... 
Via Benzinga
Topics Cannabis
News headline image
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation ↗
The Week In Psychedelics: 
Via Benzinga
Topics Intellectual Property
News headline image
Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety ↗
Image by 3D Animation Production Company from Pixabay The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team... 
Via Benzinga
News headline image
Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race ↗
Small Pharma Inc. (OTCQB:DMTTF) (TSXV: 
Via Benzinga
Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health Issues
Palm Beach, FL –October 28, 2021 – FinancialNewsMedia.com News Commentary – Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential… and for ketamine,... 
Via FinancialNewsMedia
Topics Death Law Enforcement
Two Trillion-Dollar Industries Being Transformed By Tech
FN Media Group Presents Oilprice.com Market Commentary London – October 20, 2021 – Big money is pouring into two disruptive segments in two of the world’s biggest industries – healthcare and energy.... 
Via FinancialNewsMedia
North America Continues Leading The Way In Psychedelic Wellness
Palm Beach, FL –October 26, 2021 – FinancialNewsMedia.com News Commentary – The global psychedelic drugs market remains at an early stage in its life cycle, with most companies currently developing... 
Via FinancialNewsMedia
News headline image
Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021 ↗
Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month. 
Via Talk Markets
News headline image
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗
The Week In Psychedelics 
Via Benzinga
News headline image
Psychedelic Stocks: Financial Strength, Growth Potential, Compelling Valuations ↗
Blue-chip stocks: grossly inflated valuations and loaded with debt. Psychedelic stocks: lean valuations and loaded with cash. A very attractive option in uncertain markets. 
Via Talk Markets
News headline image
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program ↗
The Week In Psychedelics 
Via Benzinga
Rising Acceptance For Treating Mental Disorders is Fueling Strong Growth in Psychedelic Drugs Market
Palm Beach, FL –October 14, 2021 – FinancialNewsMedia.com News Commentary – Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the... 
Via FinancialNewsMedia
News headline image
Former Tilray CEO Joins Psychedelics Company ↗
More big names in cannabis are switching to psychedelics. Greg Engel, former CEO of Tilray (NASDAQ: 
Via Benzinga
Topics Cannabis
News headline image
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
News headline image
MindMed Teams Up With Sphere Health To Identify Biomarkers Associated With Anxiety & Depression ↗
Psychedelic–focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) disclosed on Tuesday that it has agreed to partner with Sphere Health to... 
Via Benzinga
News headline image
Cannabis Movers & Shakers: Leafly Holdings, Linneo Health, Flowhub, MindMed ↗
Leafly Holdings Taps Suresh Krishnaswamy As New CFO The cannabis information platform Leafly Holdings, Inc. recently disclosed ... 
Via Benzinga
Topics Cannabis
U.S. Is Dominating Psychedelic Drugs Market Due To Growing Acceptance For Treating Depression & Rise In Product Approvals
Palm Beach, FL –October 12, 2021 – FinancialNewsMedia.com News Commentary – After being relegated to the margins of sincere scientific examination for about the last several decades, growing... 
Via FinancialNewsMedia
News headline image
Psychedelic Front Runners MindMed , BioXcel Patent System To Identify Agitation ↗
This article by Gaurav Dubey was originally published on 
Via Benzinga
Topics Intellectual Property
News headline image
COVID Tests, THC Patches, Psychedelics: Xphyto Therapeutics Does it All ↗
Image by Shameer Pk from Pixabay From 25-minute COVID-19 lab tests to psychedelic medicine that is poised to address mental health conditions like PTSD, XPhyto Therapeutics (... 
Via Benzinga
News headline image
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments? ↗
This article by Jason Najum was originally published on 
Via Benzinga
NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Therapeutic Options to Diseases with Unmet Needs
Via Investor Brand Network
Topics Cannabis
News headline image
Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference ↗
The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth. ... 
Via Benzinga
News headline image
Digital Therapeutics And The Future Of Psychedelic Medicine ↗
Digital health and therapeutics will play a crucial role in the future of medicine. Across medical and mental health industries, companies are real... 
Via Benzinga
Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered
Via FinancialNewsMedia
Topics Law Enforcement
News headline image
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study ↗
The Week In Psychedelics: 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.